- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic Syndromes (MDS)
Total 34465 results
-
Washington University School of MedicineNotable LabsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Seagen Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Netherlands
-
Institut Paoli-CalmettesRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Bellicum PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
The Cleveland ClinicCelgeneWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Yale UniversityWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Fox Chase Cancer CenterTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
medac GmbHCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany, Italy, Poland, France, Finland, Hungary
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Groupe Francophone des MyelodysplasiesUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
Rigshospitalet, DenmarkVan Andel Research InstituteCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeDenmark
-
Dana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
National Marrow Donor ProgramCompletedLymphoma | Myelodysplastic Syndromes | LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Oryzon Genomics S.A.Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome/Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
Affiliated Hospital to Academy of Military Medical...RecruitingMyelodysplastic Syndromes | Immunotherapy | Dendritic Cell | Hypomethylating AgentsChina
-
Groupe Francophone des MyelodysplasiesActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance, Italy
-
M.D. Anderson Cancer CenterEisai Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesTerminatedLeukemia | Myelodysplastic SyndromeCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Shanghai Bensen Pharmaceutical Co., Ltd.Not yet recruitingAcute Myeloid Leukemia, Myelodysplastic Syndrome
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicUnited States
-
Medical University of South CarolinaTerminatedMyelodysplastic Syndromes | LeukemiaUnited States
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome, High GradeSingapore
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Silence Therapeutics plcCompletedNon-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome | Very-Low Risk Myelodysplastic SyndromeThailand, Israel, Jordan, United Kingdom, Germany, Italy, Malaysia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic Syndrome With Isolated Del(5q)United States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeUnited States
-
University Hospital FreiburgActive, not recruitingMyelodysplastic Syndromes | Juvenile Myelomonocytic LeukemiaGermany
-
University of BirminghamJazz Pharmaceuticals; Adienne SA; IMPACT (funded by NHS Blood & Transplant, Anthony...Active, not recruitingAcute Myeloid Leukaemia | High-risk Myelodysplastic SyndromeUnited Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndromes | Myeloproliferative NeoplasmUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnMyelodysplastic Syndromes | Progressive DiseaseUnited States
-
Cardiff UniversityExperimental Cancer Medicine Centres; Leukaemia & Lymphoma Research GroupCompletedHigh Risk Myelodysplastic Syndrome | Acute Myeloid LeukaemiaUnited Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesChina
-
University Hospital, Basel, SwitzerlandRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSwitzerland
-
Edwin HorwitzOssium Health, Inc.SuspendedMyelodysplastic Syndromes | Acute LeukemiaUnited States
-
Seoul St. Mary's HospitalJanssen, LPUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromeKorea, Republic of